Adding a cholesterol medication to standard stroke treatment

This study is testing whether adding a medication called probucol to standard cholesterol-lowering drugs (like statins) can better protect people who have recently had a stroke caused by clogged arteries. Researchers want to know if this medication combination can prevent future strokes and heart attacks, make arterial plaques more stable, and be safe to use. About 200 people will participate, split into two groups: one receiving standard cholesterol therapy alone, and the other receiving standard therapy plus the additional medication.

After a stroke caused by clogged arteries, doctors use cholesterol-lowering medications to reduce the risk of another stroke or heart attack. However, some people still have problems even with standard treatment. This trial is exploring whether adding this medication to the standard regimen could provide extra protection by making plaques in the arteries less likely to break apart and cause another clot.